Share price close 16 Nov 2026
Quarterly or annual report filed
Quarterly or annual report filed
In one paragraph
Henry Schein reported revenue of $13.2 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), up 4.0% from fiscal 2024. Net income was $398 million and diluted earnings per share $3.27.
In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 26 Sep 2026), revenue was $3.47 billion, up 4.0% from a year earlier.
Figures from Henry Schein's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 3 Nov 2026.
Against Health Care
Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.
Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.
| Region | Revenue | Share | Change |
|---|---|---|---|
| United States | $9.10B | 69% | +3.1% |
| Other | $4.09B | 31% | +6.2% |
Henry Schein beside the other S&P 500 members in Health Care Distributors, then the largest in Health Care, by market value.
| Company | Market value | Day | 1 year | Revenue growth | Net margin | P/E |
|---|---|---|---|---|---|---|
| $9.29B | +0.1% | +18.4% | +6.2% | 3.1% | 22.1 | |
| $127.9B | +2.4% | +31.2% | +8.2% | 1.1% | 27.2 | |
| $68.14B | +2.8% | −1.2% | +5.1% | 0.8% | 26.0 | |
| $65.30B | +1.1% | +37.6% | +10.0% | 0.7% | 35.9 | |
| $1.37T | +1.1% | +41.8% | +45.5% | 31.9% | 49.6 | |
| $686.1B | +0.8% | +47.0% | +7.8% | 16.2% | 42.6 | |
| $525.9B | +0.2% | +26.5% | +10.7% | 15.7% | 51.1 |
Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.
Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.
| Revenue | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Global Distribution and Value-Added Services | $10.97B | $10.56B−3.8% | $10.76B+1.9% | $11.14B+3.5% |
| Global Specialty Products | $1.27B | $1.33B+4.6% | $1.45B+8.6% | $1.54B+6.8% |
| Global Technology | $549.0M | $602.0M+9.7% | $630.0M+4.7% | $675.0M+7.1% |
| Total revenue | $12.65B | $12.34B | $12.67B | $13.18B |
| Revenue | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| United States | $8.66B | $8.82B+1.9% | $9.10B+3.1% |
| Other | $3.68B | $3.85B+4.7% | $4.09B+6.2% |
| Total revenue | $12.34B | $12.67B | $13.18B |
Fiscal years, the latest ending 27 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.
| Period | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.57B | $12.46B | $13.20B | $9.99B | $10.12B | $12.40B | $12.65B | $12.34B | $12.67B | $13.18B |
| Revenue growth | +8.9% | +7.7% | +5.9% | −24.4% | +1.3% | +22.6% | +2.0% | −2.4% | +2.7% | +4.0% |
| Gross profit | $3.23B | $2.75B | $2.91B | $3.09B | $2.82B | $3.67B | $3.83B | $3.86B | $4.02B | $4.11B |
| Operating income | $771.6M | $669.8M | $600.6M | $718.3M | $535.0M | $852.0M | $747.0M | $615.0M | $621.0M | $653.0M |
| Net income | $506.8M | $406.3M | $535.9M | $694.7M | $404.0M | $631.0M | $538.0M | $416.0M | $390.0M | $398.0M |
| Diluted EPS | $3.10 | $2.57 | $3.49 | $4.65 | $2.82 | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |
| Gross margin | 27.9% | 22.0% | 22.0% | 31.0% | 27.8% | 29.6% | 30.3% | 31.3% | 31.7% | 31.1% |
| Operating margin | 6.7% | 5.4% | 4.5% | 7.2% | 5.3% | 6.9% | 5.9% | 5.0% | 4.9% | 5.0% |
| Net margin | 4.4% | 3.3% | 4.1% | 7.0% | 4.0% | 5.1% | 4.3% | 3.4% | 3.1% | 3.0% |
| Period | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $642.6M | $545.5M | $684.7M | $654.1M | $599.0M | $710.0M | $602.0M | $500.0M | $848.0M | $712.0M |
| Capital expenditure | $70.18M | $62.40M | $71.28M | $76.22M | $49.00M | $79.00M | $96.00M | $147.0M | $148.0M | $139.0M |
| Free cash flow | $572.4M | $483.1M | $613.4M | $577.9M | $550.0M | $631.0M | $506.0M | $353.0M | $700.0M | $573.0M |
| Period | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $62.38M | $174.7M | $56.88M | $106.1M | $421.2M | $118.0M | $117.0M | $171.0M | $122.0M | $156.0M |
| Total debt | $781.4M | $924.4M | $1.94B | $998.3M | $1.00B | $1.22B | $1.50B | $2.74B | $2.87B | $3.44B |
| Shareholders' equity | $2.79B | $2.81B | $2.96B | $3.00B | $3.35B | $3.42B | $3.45B | $3.65B | $3.39B | $3.25B |
| Diluted shares | 164M | 158M | 154M | 149M | 143M | 142M | 138M | 132M | 128M | 122M |
The last eight fiscal quarters, the latest ending 26 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.
| Period | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.19B | $3.17B | $3.24B | $3.34B | $3.44B | $3.37B | $3.46B | $3.47B |
| Revenue, year on year | +5.8% | −0.1% | +3.3% | +5.2% | +7.7% | +6.3% | +6.7% | +4.0% |
| Gross margin | 31.1% | 31.6% | 31.4% | 30.7% | 30.9% | 31.8% | 31.8% | 31.8% |
| Operating income | $155.0M | $175.0M | $151.0M | $164.0M | $163.0M | $182.0M | $171.0M | $193.0M |
| Net income | $94.00M | $110.0M | $86.00M | $101.0M | $101.0M | $107.0M | $94.00M | $119.0M |
| Diluted EPS | $0.75 | $0.88 | $0.70 | $0.84 | $0.85 | $0.92 | $0.82 | $1.06 |
| Free cash flow | $168.0M | $6.00M | $88.00M | $141.0M | $338.0M | −$122.0M | $212.0M | $131.0M |
The operating figures Henry Schein reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.
| KPI | Latest | Period | Change on a year | Recent periods |
|---|---|---|---|---|
| Global Dental revenue | $1.8B | quarter to 26 Sep 2026 | up 5.4% | |
| Global Dental Merchandise revenue | $1.3B | quarter to 26 Sep 2026 | up 7.0% | |
| Global Medical revenue | $1.1B | quarter to 26 Sep 2026 | up 1.1% | |
| Global Dental Equipment revenue | $449.0M | quarter to 26 Sep 2026 | up 2.0% | |
| Global Value-Added Services revenue | $62.0M | quarter to 26 Sep 2026 | down 3.1% | |
| Global Distribution and Value-Added Services revenue | $2.9B | quarter to 26 Sep 2026 | up 3.7% | |
| Global Specialty Products revenue | $391.0M | quarter to 26 Sep 2026 | up 6.0% | |
| Global Technology revenue | $181.0M | quarter to 26 Sep 2026 | up 4.6% | |
| United States revenue | $9.1B | fiscal year to 27 Dec 2025 | up 3.1% |
Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.
The same figures as plain text and JSON.
$13.2 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), as reported in its annual report.
$398 million for fiscal year 2025 (the twelve months to 27 Dec 2025).
$3.27 for fiscal year 2025 (the twelve months to 27 Dec 2025).
31.1% for fiscal year 2025 (the twelve months to 27 Dec 2025): gross profit divided by revenue.
5.0% for fiscal year 2025 (the twelve months to 27 Dec 2025): operating income divided by revenue.
$573 million for fiscal year 2025 (the twelve months to 27 Dec 2025): operating cash flow less capital expenditure.
In fiscal 2025, by region: United States $9.10B (69%), Other $4.09B (31%), out of $13.18B in all, as stated in its annual report.
In the terminal